Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York. The company trades on AIM exchange marketplace. The company headquarter is located in White Plains, United States. The company was established in the 2021. The company's ISIN is GB00BNNFM402.
TickerTRLS
Long NameTrellus Health plc
Short NameTrellus Health PLC
SectorHealthcare
SubsectorHealth Information Services
Subsector 2
CurrencyGBX
ISINGB00BNNFM402